<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03331926</url>
  </required_header>
  <id_info>
    <org_study_id>XIAPEX FOLLOWUP</org_study_id>
    <nct_id>NCT03331926</nct_id>
  </id_info>
  <brief_title>Collagenase is a Common Treatment of MCP and PIP Joint Contractures in Dupuytrens Disease</brief_title>
  <official_title>Collagenase Clostridium Histolytic is a Common Treatment of MCP and PIP Joint Contractures in Dupuytren Disease. A 1 to 4 Year Followup Study of 198 Joints</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Line Jensen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Horsens Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effect of collagenase clostridium histolyticum treatment at the Department of
      Orthopaedic surgery at Horsens Regional Hospital after minimum one-year follow-up (FU).
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2017</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Actual">May 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in extension deficit from baseline to FU in MCP and PIP joints after treatment</measure>
    <time_frame>Minimum one year after treatment</time_frame>
  </primary_outcome>
  <enrollment type="Actual">199</enrollment>
  <condition>Dupuytren Contracture</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Xiapex</intervention_name>
    <description>Follow-up of effect of treatment</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        All patients who received Xiapex treatment in Horsens from 2013 to May 2016 with a least 1
        years of followup.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  dupuytrens disease

          -  xiapex treatment

        Exclusion Criteria:

        - demens/other psychiatric diseases
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Charlotte Hartig-Andreasen, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Regionshospitalet Horsens</affiliation>
  </overall_official>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 26, 2017</study_first_submitted>
  <study_first_submitted_qc>November 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 6, 2017</study_first_posted>
  <last_update_submitted>November 1, 2017</last_update_submitted>
  <last_update_submitted_qc>November 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Horsens Hospital</investigator_affiliation>
    <investigator_full_name>Line Jensen</investigator_full_name>
    <investigator_title>Research secretary</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Contracture</mesh_term>
    <mesh_term>Dupuytren Contracture</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

